| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
75,554 |
63,648 |
$5.04M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,987 |
9,546 |
$2.45M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,021 |
2,009 |
$1.02M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,645 |
1,881 |
$897K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
369 |
89 |
$697K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
328 |
325 |
$672K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,012 |
1,989 |
$631K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,418 |
1,402 |
$578K |
| Q3014 |
Telehealth originating site facility fee |
22,139 |
18,993 |
$545K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,232 |
1,167 |
$537K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,542 |
1,880 |
$488K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,069 |
2,745 |
$381K |
| 36415 |
Collection of venous blood by venipuncture |
2,648 |
2,086 |
$344K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,841 |
2,785 |
$291K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
114 |
112 |
$283K |
| 77080 |
|
1,033 |
1,033 |
$272K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,385 |
1,365 |
$249K |
| 71250 |
|
1,496 |
1,493 |
$228K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,157 |
1,078 |
$218K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,073 |
1,073 |
$213K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,240 |
3,431 |
$204K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,162 |
1,674 |
$196K |
| 80053 |
Comprehensive metabolic panel |
5,796 |
4,464 |
$185K |
| 78812 |
|
66 |
66 |
$175K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,670 |
1,419 |
$166K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,202 |
2,422 |
$152K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,811 |
1,615 |
$148K |
| 71046 |
Radiologic examination, chest; 2 views |
3,007 |
2,908 |
$144K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
4,941 |
4,326 |
$137K |
| J0485 |
Injection, belatacept, 1 mg |
131 |
73 |
$111K |
| 74183 |
|
211 |
211 |
$104K |
| 90677 |
|
238 |
237 |
$103K |
| 93296 |
|
2,831 |
2,826 |
$103K |
| 78431 |
|
27 |
27 |
$98K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
722 |
719 |
$97K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,440 |
1,365 |
$94K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
965 |
863 |
$91K |
| 77386 |
|
98 |
14 |
$88K |
| 72197 |
|
104 |
103 |
$83K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
637 |
622 |
$80K |
| 77300 |
|
143 |
129 |
$78K |
| 77373 |
|
46 |
13 |
$78K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,982 |
6,881 |
$73K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
174 |
174 |
$72K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,142 |
3,881 |
$67K |
| 92557 |
|
246 |
246 |
$51K |
| 77336 |
|
289 |
175 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
138 |
93 |
$49K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
487 |
482 |
$48K |
| 77301 |
|
30 |
30 |
$48K |
| 76770 |
|
258 |
257 |
$48K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
515 |
319 |
$47K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,853 |
1,224 |
$46K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,886 |
1,840 |
$45K |
| 90662 |
|
1,745 |
1,744 |
$44K |
| 70450 |
Computed tomography, head or brain; without contrast material |
351 |
331 |
$44K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,427 |
3,102 |
$44K |
| 0760 |
|
550 |
503 |
$42K |
| J0178 |
Injection, aflibercept, 1 mg |
105 |
103 |
$42K |
| 93975 |
|
141 |
140 |
$41K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
4,236 |
1,520 |
$39K |
| 83735 |
|
3,290 |
2,174 |
$38K |
| 82565 |
|
2,785 |
2,606 |
$37K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
401 |
380 |
$37K |
| 93925 |
|
86 |
86 |
$35K |
| 72141 |
|
63 |
63 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
519 |
455 |
$34K |
| 94010 |
|
399 |
396 |
$32K |
| 92083 |
|
578 |
569 |
$32K |
| 91320 |
|
477 |
477 |
$32K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
144 |
144 |
$31K |
| 83880 |
|
453 |
389 |
$30K |
| 76536 |
|
168 |
168 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,533 |
1,466 |
$27K |
| 77334 |
|
29 |
26 |
$27K |
| 97535 |
Self-care/home management training, each 15 minutes |
497 |
413 |
$26K |
| 82947 |
|
2,469 |
2,230 |
$26K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
459 |
379 |
$26K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
366 |
366 |
$23K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
123 |
120 |
$22K |
| 96415 |
|
309 |
269 |
$20K |
| 96402 |
|
226 |
223 |
$19K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
51 |
51 |
$19K |
| 93971 |
|
87 |
86 |
$18K |
| 86900 |
|
1,348 |
1,215 |
$16K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
522 |
519 |
$15K |
| 93880 |
|
42 |
42 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
520 |
516 |
$14K |
| 85027 |
|
1,964 |
1,592 |
$14K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
422 |
312 |
$14K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
64 |
64 |
$14K |
| 77338 |
|
31 |
30 |
$14K |
| 93970 |
|
40 |
40 |
$13K |
| 84100 |
|
2,369 |
1,711 |
$13K |
| 82728 |
|
222 |
207 |
$12K |
| J3490 |
Unclassified drugs |
1,287 |
571 |
$12K |
| 80051 |
|
1,094 |
936 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,102 |
1,081 |
$11K |
| 84466 |
|
136 |
135 |
$11K |
| 93280 |
|
158 |
157 |
$11K |
| 84460 |
|
1,617 |
1,421 |
$10K |
| 84450 |
|
1,540 |
1,350 |
$10K |
| 80061 |
Lipid panel |
663 |
655 |
$10K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
13 |
13 |
$10K |
| 80197 |
|
330 |
197 |
$10K |
| 81001 |
|
2,095 |
1,976 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
540 |
507 |
$9K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
498 |
363 |
$9K |
| 82247 |
|
1,356 |
1,177 |
$9K |
| 72082 |
|
219 |
218 |
$9K |
| 86901 |
|
1,266 |
1,136 |
$9K |
| 77066 |
Tomosynthesis, mammo |
37 |
37 |
$8K |
| 0510 |
|
301 |
251 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
405 |
392 |
$8K |
| 87340 |
|
628 |
607 |
$8K |
| 84439 |
|
618 |
582 |
$8K |
| 85610 |
|
2,341 |
1,895 |
$8K |
| 84075 |
|
1,272 |
1,096 |
$8K |
| 72100 |
|
79 |
79 |
$7K |
| 87088 |
|
827 |
786 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,912 |
3,140 |
$7K |
| 82803 |
|
762 |
642 |
$7K |
| 82040 |
|
1,140 |
1,086 |
$7K |
| 82570 |
|
973 |
901 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
96 |
64 |
$6K |
| 0272 |
|
89 |
81 |
$6K |
| 86803 |
|
494 |
477 |
$6K |
| 70491 |
|
13 |
13 |
$6K |
| 76830 |
Ultrasound, transvaginal |
28 |
28 |
$6K |
| 83540 |
|
157 |
151 |
$6K |
| 0450 |
Emergency room services |
82 |
73 |
$6K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
224 |
221 |
$6K |
| 86317 |
|
551 |
525 |
$6K |
| 73502 |
|
93 |
90 |
$5K |
| 86850 |
|
495 |
465 |
$5K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
141 |
141 |
$5K |
| 82962 |
|
721 |
536 |
$5K |
| 86704 |
|
434 |
422 |
$5K |
| 99215 |
Prolong outpt/office vis |
27 |
24 |
$5K |
| 92134 |
|
1,574 |
1,532 |
$5K |
| 84295 |
|
328 |
302 |
$5K |
| 87077 |
|
245 |
243 |
$5K |
| 86665 |
|
129 |
122 |
$5K |
| 76882 |
|
25 |
25 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
593 |
542 |
$4K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
99 |
65 |
$4K |
| 84520 |
|
539 |
470 |
$4K |
| 87186 |
|
180 |
180 |
$4K |
| 90686 |
|
489 |
485 |
$4K |
| 84156 |
|
467 |
426 |
$3K |
| 92133 |
|
383 |
376 |
$3K |
| 81003 |
|
1,147 |
1,059 |
$3K |
| 82274 |
|
235 |
235 |
$3K |
| 73564 |
|
26 |
26 |
$3K |
| 74230 |
|
14 |
13 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
79 |
52 |
$3K |
| 86592 |
|
415 |
408 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
27 |
27 |
$3K |
| 86140 |
|
670 |
613 |
$3K |
| 84132 |
|
315 |
290 |
$3K |
| 73630 |
|
53 |
53 |
$3K |
| 97116 |
|
65 |
50 |
$3K |
| 96417 |
|
18 |
13 |
$2K |
| 73130 |
|
51 |
50 |
$2K |
| 83605 |
|
731 |
627 |
$2K |
| 86644 |
|
168 |
163 |
$2K |
| 86664 |
|
125 |
122 |
$2K |
| 83615 |
|
439 |
290 |
$2K |
| 90732 |
|
40 |
40 |
$2K |
| 87799 |
|
44 |
25 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
15 |
15 |
$2K |
| 82784 |
|
176 |
161 |
$2K |
| 73562 |
|
41 |
39 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
27 |
27 |
$2K |
| 73030 |
|
25 |
25 |
$2K |
| 82607 |
|
62 |
62 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
146 |
143 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
845 |
675 |
$1K |
| 85651 |
|
553 |
519 |
$1K |
| 77073 |
|
88 |
88 |
$1K |
| 82310 |
|
183 |
154 |
$1K |
| 84484 |
|
708 |
595 |
$1K |
| 93922 |
|
12 |
12 |
$1K |
| 0761 |
|
29 |
29 |
$1K |
| 93246 |
|
13 |
13 |
$1K |
| 97750 |
|
13 |
12 |
$1K |
| 90656 |
|
102 |
102 |
$997.70 |
| 99001 |
|
14 |
14 |
$985.88 |
| 86777 |
|
68 |
66 |
$977.18 |
| 82043 |
|
101 |
101 |
$947.22 |
| 87631 |
|
14 |
13 |
$889.93 |
| 87070 |
|
53 |
50 |
$867.57 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
45 |
40 |
$865.28 |
| 86780 |
|
106 |
99 |
$847.31 |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
17 |
12 |
$816.86 |
| J2704 |
Injection, propofol, 10 mg |
75 |
70 |
$766.03 |
| 93325 |
|
14 |
14 |
$716.26 |
| 85730 |
|
130 |
109 |
$709.00 |
| 87497 |
|
56 |
39 |
$689.14 |
| 84600 |
|
87 |
86 |
$684.23 |
| 83690 |
|
461 |
421 |
$665.61 |
| 73610 |
|
12 |
12 |
$642.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
110 |
92 |
$596.84 |
| 20610 |
|
13 |
13 |
$563.29 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
39 |
39 |
$557.06 |
| 85018 |
|
907 |
791 |
$522.49 |
| 92250 |
|
28 |
28 |
$507.27 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
39 |
39 |
$480.82 |
| 82746 |
|
12 |
12 |
$412.71 |
| 86787 |
|
27 |
24 |
$371.05 |
| G0008 |
Administration of influenza virus vaccine |
153 |
153 |
$347.43 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
181 |
144 |
$327.86 |
| 88112 |
|
107 |
83 |
$254.86 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
168 |
167 |
$227.73 |
| 93299 |
|
12 |
12 |
$226.25 |
| 82435 |
|
21 |
15 |
$199.28 |
| 82374 |
|
19 |
13 |
$197.04 |
| 94760 |
|
39 |
39 |
$144.83 |
| 87205 |
|
53 |
50 |
$141.75 |
| 99221 |
|
49 |
45 |
$135.04 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
195 |
138 |
$107.38 |
| J1644 |
Injection, heparin sodium, per 1000 units |
36 |
13 |
$107.01 |
| 87081 |
|
12 |
12 |
$105.32 |
| 94729 |
|
12 |
12 |
$96.46 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
44 |
38 |
$92.19 |
| 17311 |
|
16 |
15 |
$69.68 |
| 84481 |
|
15 |
13 |
$66.03 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
59 |
58 |
$53.81 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
31 |
27 |
$48.41 |
| 87040 |
|
32 |
27 |
$47.11 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
33 |
27 |
$46.15 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
233 |
144 |
$45.37 |
| 51798 |
|
12 |
12 |
$20.11 |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
19 |
16 |
$16.20 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
15 |
14 |
$15.05 |
| 81002 |
|
12 |
12 |
$10.60 |
| 82977 |
|
20 |
14 |
$6.46 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12 |
12 |
$0.05 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
48 |
40 |
$0.04 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
14 |
13 |
$0.00 |
| 99199 |
Unlisted special service, procedure or report |
16 |
13 |
$0.00 |
| 36416 |
|
60 |
54 |
$0.00 |
| 90480 |
|
14 |
14 |
$0.00 |
| 82550 |
|
12 |
12 |
$0.00 |